ZebiAI Therapeutics is a drug discovery company. Its technology applies ML and AI algorithms to protein-small molecule interaction data from DNA-encoded library (DEL) screens to accelerate target validation by providing tool compounds to the research community, and discover and optimize chemical matter into clinical candidates.